Periods of prolonged hypoxia are associated clinically with an increased incidence of dementia, the most common form of which is Alzheimer's disease. Here, we review recent studies aimed at providing a cellular basis for this association. Hypoxia promoted an enhanced secretory response of excitable cells via formation of a novel Ca 2C influx pathway associated with the formation of amyloid peptides of Alzheimer's disease. More strikingly, hypoxia potentiated Ca 2C influx specifically through L-type Ca 2C channels in three distinct cellular systems. This effect was post-transcriptional, and evidence suggests it occurred via increased formation of amyloid peptides which alter Ca 2C channel trafficking via a mechanism involving increased production of reactive oxygen species by mitochondria. This action of hypoxia is likely to contribute to dysregulation of Ca 2C homeostasis, which has been proposed as a mechanism of cell death in Alzheimer's disease. We suggest, therefore, that our data provide a cellular basis to account for the known increased incidence of Alzheimer's disease in patients who have suffered prolonged hypoxic episodes.
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Keywords: hypoxia; calcium channel; Alzheimer's disease; reactive oxygen species 1. HYPOXIA AND ALZHEIMER'S DISEASE: THE CLINICAL EVIDENCE Adaptation to conditions of chronic hypoxia is usually only seen in healthy individuals when they spend prolonged periods of time at high altitude. However, arterial O 2 levels can be markedly reduced at sea level in patients suffering from a wide variety of cardiorespiratory diseases. Examples include congestive heart failure, chronic obstructive pulmonary disease and emphysema. Prolonged periods of hypoxia can lead to damage of higher brain functions such as memory and cognition and indeed, a wealth of clinical reports indicate clearly that in such individuals the likelihood of subsequently developing dementias-particularly Alzheimer's disease-is greatly increased (Incalzi et al. 1993; Tatemichi et al. 1994; Kokmen et al. 1996; Moroney et al. 1996) . Our limited understanding of this important clinical link is that it appears to occur because hypoxia can promote selectively the expression of genes which encode key proteins associated with Alzheimer's disease (Kogure & Kato 1993; Koistinaho et al. 1996) . However, the mechanisms underlying such effects, and their physiological consequences, have not, to date, been studied in depth and so our current awareness is poor. Nevertheless, the clear link between hypoxic/ischaemic episodes and increased incidence of Alzheimer's disease strongly suggests that one or more of these parameters are capable of precipitating this increasingly widespread disease.
HYPOXIA AND ALZHEIMER'S DISEASE: EVIDENCE FOR CELLULAR MECHANISMS
Our previous studies, along with those of others, have shown that prolonged hypoxia causes dramatic changes in the functional expression of key proteins (particularly ion channels) in neuronally derived cells and cell lines (Wyatt et al. 1995; Taylor et al. 1999; Green & Peers 2001; Peers & Kemp 2001; Colebrooke et al. 2002) and also, more recently, in primary cultures of central neurons (Plant et al. 2002) . Most importantly, we have shown that many of these effects of hypoxia involve formation of amyloid b peptides (AbPs) associated with Alzheimer's disease and can be mimicked by exposing cells to AbPs under normoxic conditions. Indeed, these dramatic effects of hypoxia appear to require formation of AbPs (Taylor et al. 1999; . Thus, of all the parameters required for normal cell function that can be disturbed during hypoxic/ischaemic episodes (e.g. lack of substrates, acidosis, accumulation of metabolic waste products) reduction in available O 2 appears to be a crucial factor in the initiation of Alzheimer's disease.
HYPOXIA AND EXOCYTOSIS
A wealth of evidence suggests that neuronal cell death in Alzheimer's disease arises from disruption of Ca 2C homeostasis. We first provided potential support for this in the actions of chronic hypoxia when examining exocytosis from individual PC12 cells, which release catecholamines in response to depolarizing stimuli that is dependent on voltage-gated Ca 2C entry. Exocytosis was monitored in real time, using single cell amperometry (Wightman et al. 1991; Finnegan et al. 1996) . As shown in figure 1a, (Lorenzo & Yankner 1994; Rhee et al. 1998) , suggesting the surprising possibility that a 12-24 h period of hypoxia induced formation of Ca 2C -permeable amyloid peptide channels which coupled closely to exocytosis. In further support of this, we found that exposure of cells to a monoclonal antibody (3D6) raised against the extracellularly located N 0 terminus of amyloid peptides (anti-AbP 1-5 ; JohnsonWood et al. 1997) for 1 h at 37 8C also significantly suppressed the Cd 2C -resistant component of the secretory response (figure 1b). These findings strongly suggested that hypoxia caused formation of Ca 2C permeable channels which were tightly coupled to exocytosis and are in some way associated with amyloid peptide formation.
HYPOXIA AND NATIVE Ca
2C CHANNELS Clearly, the implied amyloid-related Ca 2C entry pathway required further study. We therefore used wholecell patch clamp recordings to monitor Ca 2C influx directly, and we identified a marked increase in whole cell Ca 2C current density in cells cultured under hypoxic conditions (2.5% O 2 , 24 h), as compared with normoxic, control cells ( figure 2a,b) . Interestingly, this effect of hypoxia could be mimicked by exposure of cells to amyloid peptides, either Ab (1-40) (figure 2c) or Ab (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (figure 2d ) . This was in accordance with the studies on exocytosis (figure 1). However, when cells were exposed to Cd 2C currents were virtually completely blocked (figure 2), suggesting that any Cd 2C -resistant Ca 2C influx pathway was extremely small. Closer inspection revealed this to be the case: figure 2e,f illustrates mean Ca 2C currents recorded in the presence of Cd 2C in hypoxic (figure 2e) and Ab (1-40) (figure 2f ) treated cells. Note that this current could be fully blocked by the 3D6 monoclonal antibody. Note also that these tiny currents could not account for the marked increase in total whole-cell Ca 2C current, indicating that an additional effect of hypoxia (and amyloid) must have occurred.
PC12 cells, like many excitable neuronal or neuroendocrine cells, possess multiple types of voltage-gated Ca 2C channels. Of these, we found that hypoxia appeared to selectively increase the L-type Ca 2C channels in these cells, as reflected in the increased sensitivity to 2 mM nifedipine (figure 3a,b). This was also the case in cells treated with amyloid peptides (figure 3c,d ). It was noteworthy that the nifedipine-resistant current densities in each cell group were similar. Thus, hypoxia (and amyloid peptides) selectively augmented L-type Ca 2C currents. While such effects were interesting, they were somewhat removed from the question of development of Alzheimer's disease, since they were performed in a clonal cell line. Thus, to address a more pertinent cell type, we examined this phenomenon in cerebellar granule neurons (CGNs). Figure 4a indicates that, as in PC12 cells, Ca 2C currents recorded in CGNs were augmented by a period of hypoxia, and this effect was not seen when the L-type component of the Ca 2C current was blocked by nifedipine (figure 4b). At the same time, immunoreactivity for amyloid b peptide was markedly enhanced in these cells (figure 4c), an effect which was fully blocked by inhibition of either b-or g-secretase, the two enzymes required for cleavage of Ab from its precursor protein, APP (figure 4c). This was a primary indication that the effects of hypoxia required Ab formation. Amyloid immunoreactivity was examined using the monoclonal antibody, 3D6 ( Johnson-Wood et al. 1997) . Open circles show data from identically treated cells, except that they were exposed to the 3D6 antibody (5 mg ml
K1
; 1 h). ( f ) As in (e), except that cells were exposed to amyloid petides (as in (c)) rather than hypoxia (nZ8-15 cells in each case). current augmentation by either hypoxia (figure 5a) or by AbPs ( figure 5b) . Furthermore, the effect of hypoxia could be almost fully inhibited by co-incubation with inhibitors of either b-or g-secretases (figure 5c), again indicating that the effects of hypoxia required amyloid formation. This finding suggested that hypoxia did not augment current amplitudes via transcriptional regulation of the channel protein, since such transcription was under the control of the promoter regions of the plasmid introduced artificially into the HEK-293 cells.
We reasoned, therefore, that increased functional expression might be attributed to a post-transcriptional event such as altered trafficking. Initial studies using double immunohistochemistry suggested that amyloid peptides and the a 1C subunit co-localized, particularly under hypoxic conditions (Scragg et al. 2005 ). To probe further the possible association of these two proteins, we performed immunoprecipitation and western blot experiments. Figure 6a shows blots taken from homogenates precipitated using the 3D6 (anti-amyloid) antibody then probed with the anti-a 1C antibody. In control cells (left), the signal was extremely weak. However, a clear band of appropriate molecular weight was detected in hypoxic cells (right). These results (representative of six paired experiments) were supported in experiments where homogenates were precipitated with the anti-a 1C antibody then probed using the 3D6 antibody (figure 6b). In this case, amyloid peptides were detected in both control (figure 6b, left) and hypoxic (right) cell samples, proof of physical interaction under both conditions, but band intensity was consistently (nZ6 experiments) greater in hypoxic samples.
Figure 6c plots mean current densities (taken at the membrane potential at which currents were maximal in amplitude) in control cells, and those cultured under hypoxic conditions or in the presence of amyloid peptides. Also shown are data obtained from hypoxic or amyloid-treated cells following a 1 h period in which cells were also exposed to 5 mg ml K1 of the 3D6 monoclonal antibody. The antibody fully reversed current augmentation under either experimental condition. This effect was comparable to the effects of autoantibodies present in the plasma of patients with Lambert-Eaton myasthenic syndrome (Vincent et al. 1989 ), who present with muscular weakness due to suppression of acetylcholine (ACh) release from motor nerve terminals. ACh release is suppressed because autoantibodies bind to, and cross-link, presynaptic Ca 2C channels (Vincent et al. 1989; Peers et al. 1993) . This cross-linking in turn triggers endocytotic downregulation of channels. With this in mind, an attractive (though still speculative) explanation for the present studies is that 3D6 antibodies also trigger downregulation of a 1C subunits via cross-linking of adjacent amyloid peptides which our co-immunoprecipitation experiments (figure 6a,b) suggest are tightly coupled.
THE INVOLVEMENT OF REACTIVE OXYGEN SPECIES IN HYPOXIC CURRENT AUGMENTATION
A growing body of evidence suggests that hypoxia can, seemingly paradoxically, cause an increase in the generation of reactive oxygen species (ROS; e.g. Duranteau et al. 1998; Chandel & Schumacker 2000; Waypa & Schumacker 2005) . The ROS appear to be derived specifically from mitochondria. To examine whether ROS were involved in hypoxia-induced increases of Ca 2C channel currents, we examined the effects of antioxidants. Results are exemplified by the action of ascorbic acid (figure 7a), which fully prevented the augmentation of currents by hypoxia, while leaving control (normoxic) currents unaffected (not shown). Furthermore, this inhibitory effect of ascorbic acid was mimicked by co-culturing cells under hypoxic conditions in the additional presence of rotenone, an inhibitor of complex I of the mitochondrial electron transport chain. Thus, again, hypoxic augmentation of currents was fully blocked (figure 7b). These findings are in accordance with the suggestion of Schumacker and colleagues (e.g. Chandel & Schumacker 2000; Waypa & Schumacker 2005 ) that hypoxia increases ROS production from mitochondria.
CONCLUSIONS
The data presented herein provide a plausible cellular basis for the known association of prolonged hypoxia and dementia, as documented in several clinical studies (Incalzi et al. 1993; Tatemichi et al. 1994; Kokmen et al. 1996; Moroney et al. 1996) . In PC12 cells, we noted two distinct effects of hypoxia-the induction of a Cd 2C -resistant Ca 2C influx pathway which was tightly coupled to exocytosis, and the selective upregulation of L-type Ca 2C channels. Both effects involve amyloid b peptide formation. Indeed, where tested, the effects of hypoxia require amyloid formation, since inhibitors of either b-or g-secretases (the enzymes required for cleavage of amyloid peptide from its precursor; Mattson 1997; Vassar & Citron 2000; LaFerla 2002) prevented effects of hypoxia.
The induction of an amyloid-associated influx pathway coupled to exocytosis has not been explored further in detail, but is reminiscent of amyloidmediated ion channel activity previously reported (Arispe et al. , 1996 Pollard et al. 1993) . These previous studies have suggested that small aggregates of amyloid peptides can form membrane-spanning, Ca 2C permeable ion channels, thereby contributing to the dysregulation of Ca 2C homeostasis believed to be involved in neuronal cell death in Alzheimer's disease (LaFerla 2002) . Further studies are require to explore this possibility but it is important to note that hypoxic induction of this influx pathway is distinct from the effect of hypoxia to upregulate native L-type Ca 2C channels. The distinction is emphasized by our findings that the influx pathway coupled to secretion was unaffected by inhibitors of the transcriptional regulator NFk-B, whereas the enhancement of L-type Ca The most striking effect of hypoxia was the enhancement of L-type Ca 2C channels, a phenomenon which was observed not only in PC12 cells, but also in central neurons and a recombinant expression system. This in itself suggests the effect is not tissue specific and so is likely to be a widespread effect. Most importantly, in all cell types this effect of hypoxia required amyloid formation. It is this requirement which convinces us that Ca 2C channel upregulation provides a cellular basis for the clinical association of hypoxia with dementia (see above). L-type Ca 2C channels serve a variety of important functions (Lipscombe et al. 2000; Striessnig et al. 2004; Wang et al. 2004) , and so their selective targeting by amyloid peptides is likely to have profound (and deleterious) effects on cell activity and survival.
The fact that we could reproduce the effects of hypoxia on L-type Ca 2C channels in a recombinant expression system allowed us to draw immediate conclusions. First, channel upregulation was unlikely to occur via increased channel gene transcription, since the gene was part of a foreign plasmid incorporated into these cells which contained no known hypoxia-sensitive regions. Second, channel upregulation did not require the presence of auxiliary subunits. Normally L-type (and other) Ca 2C channels are protein complexes, with auxiliary subunits regulating normal channel activity (Dolphin 1995; Yamaguchi et al. 1998) . Our recombinant expression system lacked auxiliary subunits, yet amyloid mediated hypoxic enhancement of currents was striking.
Looking for post-transcriptional mechanisms, we explored the possibility that amyloid peptides might act as chaperone molecules, altering the trafficking of Ca 2C channels. Evidence to support this idea came from a striking increase in the co-localization of the two proteins, as determined by double-labelling immunocytochemistry (Scragg et al. 2005) . Furthermore, the two proteins co-immunoprecipitated (figure 6), suggesting they physically interact (although how direct this is, we cannot currently determine). We propose that this association is also present at the plasma membrane, since exposure of hypoxic (or amyloidtreated) cells to the 3D6 antibody raised against amyloid peptide suppressed any enhancement of current amplitude.
Importantly, we also provided evidence that the effects of hypoxia require formation of ROS. This is a contentious issue, since some groups believe ROS to increase during hypoxia (Waypa & Schumacker 2005) , while others believe ROS levels to decrease in hypoxia (Michelakis et al. 2004) , even when studied in the same tissue. The latter opinion is the more instinctive, since ROS are derived from O 2 , yet compelling evidence is accumulating for the former. Our findings are consistent with the idea that increased production of ROS is required for the observed effects of hypoxia on Ca 2C channels. Thus, not only do antioxidants prevent any effects of hypoxia, but exposure of cells to H 2 O 2 mimics the effects of hypoxia . Furthermore, hypoxic ROS generation appears to be from mitochondria (figure 7), in accordance with other studies (Waypa & Schumacker 2005) .
A key fundamental question is how hypoxia triggers increased amyloidogenic processing (i.e. the formation of amyloid peptides from their precursor protein, APP). We are currently exploring the alternative processing pathways of APP, and our recent findings suggest that increased amyloid formation might arise due to increased expression of presenilin-1, the major component of g-secretase, essential for amyloid formation (Smith et al. 2004) . Clearly there is much further work to be done, but our data to date provide a plausible cellular basis to account for the known increased incidence of Alzheimer's disease in patients who have suffered prolonged hypoxic episodes.
